Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01362621 · ClinicalTrials.gov registry record
Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma
A clinical trial, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- 474
- Enrollment target
NCT01362621 is a clinical trial that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 474 participants.
The verdict
NCT01362621 has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- 474 participants
- Enrollment target
Study Summary
The study was designed to collect data about inadequately controlled moderate to severe allergic asthma in subjects 6 to \< 12 years of age, managed in a real-world setting.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 474 participants |
| Start Date | 2008-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01362621
The ClinicalTrials.gov registry entry for NCT01362621 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 474 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01362621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01362621 about?
NCT01362621 is a clinical study titled "Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma". The study was designed to collect data about inadequately controlled moderate to severe allergic asthma in subjects 6 to \< 12 years of age, managed in a real-world setting.
What is the current status of trial NCT01362621?
This trial is currently completed. The enrollment target is 474 participants. The study started on 2008-02.
Who is sponsoring clinical trial NCT01362621?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.